Tobias Keck
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 162
- Colorectal Cancer Surgical Treatments 19
- Cancer Research top 1%
- Surgery top 0.5%
- Pancreatitis Pathology and Treatment 91
- Cholangiocarcinoma and Gallbladder Cancer Studies 20
-
- Gallbladder and Bile Duct Disorders 40
- Gastric Cancer Management and Outcomes 24
- Renal cell carcinoma treatment 19
- Gastroenterology top 2%
-
- Neuroendocrine Tumor Research Advances 44
- Co-authors
- Ulrich F. WellnerUlrich T. HoptFrank MakowiecAxel zur HausenThomas BrabletzDirk BauschUlrich AdamHartwig Riediger
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Tobias Keck
278 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 4.0k
- Cancer Research 1.2k
- Surgery 2.9k
- Pulmonary and Respiratory Medicine 1.6k
- Gastroenterology 226
Countries citing papers authored by Tobias Keck
This map shows the geographic impact of Tobias Keck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Keck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Keck more than expected).
Fields of papers citing papers by Tobias Keck
This network shows the impact of papers produced by Tobias Keck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Keck. The network helps show where Tobias Keck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tobias Keck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).breakdown → | 2024 | 37 |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 19 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 13 | |
| 18 | 2020 | 7 | |
| 19 | 2017 | 8 | |
| 20 | 2012 | 8 |
About Tobias Keck
Tobias Keck is a scholar working on Oncology, Surgery and Gastroenterology, having authored 300 papers that have together received 6.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (162 papers), Pancreatitis Pathology and Treatment (91 papers), Neuroendocrine Tumor Research Advances (44 papers), Gallbladder and Bile Duct Disorders (40 papers), Gastric Cancer Management and Outcomes (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Renal cell carcinoma treatment (19 papers) and Colorectal Cancer Surgical Treatments (19 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.2k citations) and Surgery (2.9k citations). Tobias Keck has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Ulrich F. Wellner, Ulrich T. Hopt, Frank Makowiec, Axel zur Hausen, Thomas Brabletz, Dirk Bausch, Ulrich Adam, Hartwig Riediger, Simone Brabletz and Ulrike Burk. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.